Voyager Therapeutics (VYGR) Share-based Compensation (QoQ) (2014 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) Share-based Compensation (QoQ) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.23 Bn | 9.38 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.05 Bn | 5.05 Bn | - |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.59 Bn | 2.63 Bn | 251.50 Mn |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.22 Bn | 1.42 Bn | 251.87 Mn |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn |
| 10 | Voyager Therapeutics | 192.24 Mn | 75.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 110.22% |
| Mar 31, 2026 | 36.32% |
| Dec 31, 2025 | -65.06% |
| Sep 30, 2025 | -2.59% |
| Jun 30, 2025 | -6.79% |
| Mar 31, 2025 | 196.99% |
| Dec 31, 2024 | -57.88% |
| Sep 30, 2024 | 0.06% |
| Jun 30, 2024 | -0.49% |
| Mar 31, 2024 | 192.60% |
| Dec 31, 2023 | -60.69% |
| Sep 30, 2023 | 5.60% |
| Jun 30, 2023 | -0.35% |
| Mar 31, 2023 | 213.76% |
| Dec 31, 2022 | -61.41% |
| Sep 30, 2022 | -8.30% |
| Jun 30, 2022 | -2.87% |
| Mar 31, 2022 | 312.65% |
| Dec 31, 2021 | -69.40% |
| Sep 30, 2021 | -8.67% |